Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|November 29, 2007

Siemens’ CAD shines at RSNA 2007

Computer-aided detection figures prominently in the Siemens Medical Systems booth at this year’s RSNA meeting. The company is featuring packages for colon cancer, pulmonary embolism, and lung nodules in several work-in-progress versions.

Computer-aided detection figures prominently in the Siemens Medical Systems booth at this year's RSNA meeting. The company is featuring packages for colon cancer, pulmonary embolism, and lung nodules in several work-in-progress versions. Syngo Lung CAD will offer solid nodule detection - improved over the currently available commercial version - that will use a new CAD Manager to present results on PACS workstations. Syngo PE Detection will distinguish segmental and subsegmental filling defects in CT angiography studies of the thorax. Syngo Colonography PEV includes enhancements in the visualization of flat polyps. Syngo MammoCAD, although validated on the company's Mammomat NovationDR full-field digital mammography system and syngo MammoReport soft-copy reading and reporting workstation, has not yet been approved for sale in the U.S.


Related to this article

See the Real-World Impact of AI in Radiology
AI has to do more than show potential. It has to deliver measurable results.The Rad AI Outcomes and Market Impact Compendium brings together real-world clinical, operational and financial evidence from health systems, academic medical centers and radiology practices using Rad AI Reporting, Impressions and Continuity.Explore results including 60+ minutes saved per radiologist shift, a 47% reduction in report error rates, 70%+ patient follow-up adherence and >7x ROI — plus, case studies showing how organizations are translating AI into greater capacity, quality and financial performance.See what AI built specifically for radiology can deliver in practice.